Sign inGet started

OVID

Ovid Therapeutics Inc.CIK 1636651 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22

AI insights for OVID PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for OVID
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Carter Charles RossChief Financial Officer1$0$02026-07-06
Greka AnnaDirector1$0$02026-06-15
Fitzgerald Kevin JosephDirector8$0$02026-04-07
Friedman BartDirector14$0$02026-04-07
PAPADOPOULOS STELIOSDirector3$0$02026-04-07
LEVIN JEREMY MExecutive Chairman29$509.6K$02026-03-23
ALEXANDER MARGARET A.President and COO8$5.0K$19.9K2026-02-26
Bernstein KarenDirector16$82.5K$02026-02-26
Duncan Barbara GayleDirector15$0$02026-02-26
Rona Jeffrey AChief Business Officer17$0$14.6K2026-02-26
Takeda Pharmaceuticals U.S.A., Inc.10% Owner2$0$02025-12-08
Poole Robert MichaelDirector4$0$02024-02-22
Tardio JasonChief Operating Officer13$0$37.3K2024-02-22
Perone Thomas MichaelSVP, General Counsel12$0$02024-02-22
TAKEDA PHARMACEUTICAL CO LTD10% Owner5$5.00M$02022-07-01
Rakhit AmitPresident and CMO10$0$126.2K2021-07-14
WILLIAMS DOUGLAS EDirector7$32.5K$02021-05-17
Haasner DirkSVP, Global Regulatory Affairs6$0$02020-12-17
Daly TimothyVP, Finance & Corp. Controller7$0$02020-12-17
During MatthewPresident and CSO5$0$02019-04-01
Ward AnaSVP and General Counsel4$0$02019-02-24
Werber YaronCBO, CFO, Sec. and Treas.2$0$02018-01-19

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Carter Charles RossChief Financial Officer A Award2026-07-062026-07-0850,000— $094,375SEC↗
Greka AnnaDirector A Award deriv2026-06-152026-06-17130,000— $0130,000SEC↗
Fitzgerald Kevin JosephDirector A Award2026-04-072026-04-0917,578$2.56 $45.0K17,578SEC↗
Friedman BartDirector A Award2026-04-072026-04-098,789$2.56 $22.5K8,789SEC↗
PAPADOPOULOS STELIOSDirector A Award2026-04-072026-04-0917,578$2.56 $45.0K217,578SEC↗
LEVIN JEREMY MExecutive Chairman M Exercise deriv2026-03-232026-03-2547,333— $00SEC↗
LEVIN JEREMY MExecutive Chairman M Exercise2026-03-232026-03-2547,333$1.40 $66.3K3,735,048SEC↗
LEVIN JEREMY MDirector A Award deriv2026-02-262026-03-02957,000— $0957,000SEC↗
ALEXANDER MARGARET A.President and CEO A Award deriv2026-02-262026-03-021,435,000— $01,435,000SEC↗
Rona Jeffrey ACBFO A Award deriv2026-02-262026-03-02408,750— $0408,750SEC↗
Bernstein KarenDirector A Award deriv2026-02-262026-03-0265,000— $065,000SEC↗
DUNCAN BARBARA GAYLEDirector A Award deriv2026-02-262026-03-0265,000— $065,000SEC↗
Friedman BartDirector A Award deriv2026-02-262026-03-0265,000— $065,000SEC↗
Fitzgerald Kevin JosephDirector A Award deriv2026-02-262026-03-0265,000— $065,000SEC↗
PAPADOPOULOS STELIOSDirector A Award deriv2026-02-262026-03-0265,000— $065,000SEC↗
Rona Jeffrey ACBFO A Award2026-02-262026-03-0268,125— $0156,313SEC↗
ALEXANDER MARGARET A.President and CEO S Sale2026-02-232026-03-0211,656$1.45 $16.9K61,750SEC↗
Rona Jeffrey ACBFO S Sale2026-02-232026-03-028,541$1.45 $12.4K88,188SEC↗
ALEXANDER MARGARET A.President and CEO A Award deriv2026-01-042026-01-05890,000— $0890,000SEC↗
LEVIN JEREMY MCEO C Conversion deriv2025-12-152025-12-1871— $00SEC↗
LEVIN JEREMY MCEO C Conversion2025-12-152025-12-1871,000— $03,687,715SEC↗
LEVIN JEREMY MCEO P Buy deriv2025-12-112025-12-1835,500— $035,500SEC↗
LEVIN JEREMY MCEO P Buy deriv2025-12-112025-12-1871— $071SEC↗
LEVIN JEREMY MCEO P Buy deriv2025-12-112025-12-1847,333— $047,333SEC↗
Takeda Pharmaceuticals U.S.A.,10% Owner C Conversion deriv2025-12-082025-12-091,250— $00SEC↗
Takeda Pharmaceuticals U.S.A.,10% Owner C Conversion2025-12-082025-12-091,250,000— $07,000,000SEC↗
PAPADOPOULOS STELIOSDirector A Award deriv2025-03-032025-03-0490,000— $090,000SEC↗
Rona Jeffrey ACBFO S Sale2025-02-262025-02-283,902$0.56 $2.2K67,973SEC↗
ALEXANDER MARGARET A.President and COO S Sale2025-02-262025-02-285,279$0.56 $3.0K73,406SEC↗
Bernstein KarenDirector A Award deriv2025-02-202025-06-1845,000— $045,000SEC↗
Duncan Barbara GayleDirector A Award deriv2025-02-202025-06-1845,000— $045,000SEC↗
Friedman BartDirector A Award deriv2025-02-202025-06-1845,000— $045,000SEC↗
Fitzgerald Kevin JosephDirector A Award deriv2025-02-202025-06-1845,000— $045,000SEC↗
ALEXANDER MARGARET A.President and COO A Award deriv2025-02-202025-02-24262,500— $0262,500SEC↗
Rona Jeffrey ACBFO A Award deriv2025-02-202025-02-24262,500— $0262,500SEC↗
LEVIN JEREMY MCEO A Award deriv2025-02-202025-02-241,650,000— $01,650,000SEC↗
ALEXANDER MARGARET A.President and COO A Award2025-02-202025-02-2443,750— $078,685SEC↗
Rona Jeffrey ACBFO A Award2025-02-202025-02-2443,750— $071,875SEC↗
ALEXANDER MARGARET A.President and COO P Buy2025-01-272025-01-296,810$0.73 $5.0K34,935SEC↗
Bernstein KarenDirector A Award deriv2024-12-122024-12-1690,000— $090,000SEC↗
Duncan Barbara GayleDirector A Award deriv2024-12-122024-12-1690,000— $090,000SEC↗
Friedman BartDirector A Award deriv2024-12-122024-12-1690,000— $090,000SEC↗
Fitzgerald Kevin JosephDirector A Award deriv2024-12-122024-12-1690,000— $090,000SEC↗
ALEXANDER MARGARET A.President and COO A Award deriv2024-09-092024-09-11140,000— $0140,000SEC↗
Rona Jeffrey ACBFO A Award deriv2024-07-302024-08-01315,000— $0315,000SEC↗
LEVIN JEREMY MCEO P Buy2024-03-182024-03-2018,248$2.76 $50.4K3,616,715SEC↗
Bernstein KarenDirector A Award deriv2024-02-222024-02-2630,000— $030,000SEC↗
Duncan Barbara GayleDirector A Award deriv2024-02-222024-02-2630,000— $030,000SEC↗
Fitzgerald Kevin JosephDirector A Award deriv2024-02-222024-02-2630,000— $030,000SEC↗
Friedman BartDirector A Award deriv2024-02-222024-02-2630,000— $030,000SEC↗
LEVIN JEREMY MCEO A Award deriv2024-02-222024-02-26700,000— $0700,000SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2024-02-222024-02-26168,750— $0168,750SEC↗
Poole Robert MichaelDirector A Award deriv2024-02-222024-02-2630,000— $030,000SEC↗
Rona Jeffrey ACBFO A Award deriv2024-02-222024-02-26168,750— $00SEC↗
Tardio JasonChief Operating Officer A Award deriv2024-02-222024-02-26168,750— $0168,750SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award2024-02-222024-02-2628,125— $028,125SEC↗
Rona Jeffrey ACBFO A Award2024-02-222024-02-2628,125— $028,125SEC↗
Tardio JasonChief Operating Officer A Award2024-02-222024-02-2628,125— $028,125SEC↗
LEVIN JEREMY MCEO G Gift2023-12-042023-12-06573,275— $04,171,742SEC↗
LEVIN JEREMY MCEO G Gift2023-12-042023-12-06573,275— $03,598,467SEC↗
Bernstein KarenDirector A Award deriv2023-02-232023-02-2715,000— $015,000SEC↗
Duncan Barbara GayleDirector A Award deriv2023-02-232023-02-2715,000— $015,000SEC↗
Fitzgerald Kevin JosephDirector A Award deriv2023-02-232023-02-2715,000— $015,000SEC↗
Friedman BartDirector A Award deriv2023-02-232023-02-2715,000— $015,000SEC↗
LEVIN JEREMY MCEO A Award deriv2023-02-232023-02-27600,000— $0600,000SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2023-02-232023-02-27175,000— $0175,000SEC↗
Poole Robert MichaelDirector A Award deriv2023-02-232023-02-2715,000— $015,000SEC↗
Rona Jeffrey ACBFO A Award deriv2023-02-232023-02-27175,000— $0175,000SEC↗
Tardio JasonChief Operating Officer A Award deriv2023-02-232023-02-27175,000— $0175,000SEC↗
Tardio JasonChief Operating Officer S Sale2022-09-122022-09-1417,344$2.15 $37.3K0SEC↗
TAKEDA PHARMACEUTICAL CO LTD10% Owner J Other deriv2022-07-012022-07-061,250— $01,250SEC↗
TAKEDA PHARMACEUTICAL CO LTD10% Owner J Other deriv2022-07-012022-07-061,250— $00SEC↗
TAKEDA PHARMACEUTICAL CO LTD10% Owner J Other2022-07-012022-07-065,750,000— $05,750,000SEC↗
TAKEDA PHARMACEUTICAL CO LTD10% Owner J Other2022-07-012022-07-065,750,000— $00SEC↗
Bernstein KarenDirector A Award deriv2022-04-082022-04-1269,424— $069,424SEC↗
Duncan Barbara GayleDirector A Award deriv2022-04-082022-04-1221,347— $021,347SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2022-04-082022-04-1210,000— $010,000SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2022-04-082022-04-1225,399— $025,399SEC↗
Rona Jeffrey ACBFO A Award deriv2022-04-082022-04-1210,000— $010,000SEC↗
Rona Jeffrey ACBFO A Award deriv2022-04-082022-04-12194,399— $0194,399SEC↗
LEVIN JEREMY MCEO A Award deriv2022-04-082022-04-12423,244— $0423,244SEC↗
Tardio JasonChief Operating Officer A Award deriv2022-04-082022-04-1287,498— $087,498SEC↗
Tardio JasonChief Operating Officer A Award deriv2022-04-082022-04-1210,000— $010,000SEC↗
Friedman BartDirector A Award deriv2022-04-082022-04-1269,424— $069,424SEC↗
LEVIN JEREMY MCEO A Award deriv2022-02-032022-02-04600,000— $0600,000SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2022-02-032022-02-04175,000— $0175,000SEC↗
Rona Jeffrey ACBFO A Award deriv2022-02-032022-02-04218,750— $0218,750SEC↗
Tardio JasonChief Operating Officer A Award deriv2022-02-032022-02-04175,000— $0175,000SEC↗
Bernstein KarenDirector A Award deriv2022-02-032022-02-0415,000— $015,000SEC↗
Duncan Barbara GayleDirector A Award deriv2022-02-032022-02-0415,000— $015,000SEC↗
Fitzgerald Kevin JosephDirector A Award deriv2022-02-032022-02-0415,000— $015,000SEC↗
Friedman BartDirector A Award deriv2022-02-032022-02-0415,000— $015,000SEC↗
Poole Robert MichaelDirector A Award deriv2022-02-032022-02-0415,000— $015,000SEC↗
Fitzgerald Kevin JosephDirector A Award deriv2021-10-062021-10-0730,000— $030,000SEC↗
Rakhit AmitPresident and CMO M Exercise deriv2021-07-142021-07-1634,017— $090,983SEC↗
Rakhit AmitPresident and CMO S Sale2021-07-142021-07-1634,017$3.71 $126.2K726,823SEC↗
Rakhit AmitPresident and CMO M Exercise2021-07-142021-07-1634,017$1.89 $64.3K760,840SEC↗
Poole Robert MichaelDirector A Award deriv2021-07-092021-07-1330,000— $030,000SEC↗
Tardio JasonChief Commercial Officer A Award deriv2021-07-012021-07-0150,000— $050,000SEC↗
Bernstein KarenDirector A Award deriv2021-06-112021-06-1115,000— $015,000SEC↗
Friedman BartDirector A Award deriv2021-06-112021-06-1115,000— $015,000SEC↗
Duncan Barbara GayleDirector A Award deriv2021-06-112021-06-1115,000— $015,000SEC↗
Rona Jeffrey AChief Business Officer A Award deriv2021-06-022021-06-10100,000— $0100,000SEC↗
Bernstein KarenDirector A Award deriv2021-05-172021-05-181,750— $01,750SEC↗
Duncan Barbara GayleDirector A Award deriv2021-05-172021-05-181,750— $01,750SEC↗
Friedman BartDirector A Award deriv2021-05-172021-05-181,750— $01,750SEC↗
WILLIAMS DOUGLAS EDirector A Award deriv2021-05-172021-05-181,750— $01,750SEC↗
Tardio JasonChief Commercial Officer A Award deriv2021-02-052021-02-0875,000— $075,000SEC↗
Daly TimothyEVP,Finance & Corp. Controll A Award deriv2020-12-172020-12-21125,000— $0125,000SEC↗
Haasner DirkSVP, Global Regulatory Affai A Award deriv2020-12-172020-12-21100,000— $0100,000SEC↗
LEVIN JEREMY MCEO A Award deriv2020-12-172020-12-21650,000— $0650,000SEC↗
Rakhit AmitPresident and CMO A Award deriv2020-12-172020-12-21200,000— $0200,000SEC↗
Rona Jeffrey AChief Business Officer A Award deriv2020-12-172020-12-21175,000— $0175,000SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2020-12-172020-12-21175,000— $0175,000SEC↗
Tardio JasonChief Commercial Officer A Award deriv2020-12-172020-12-21175,000— $0175,000SEC↗
Tardio JasonChief Commercial Officer A Award deriv2020-11-252021-04-2944,000— $044,000SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2020-11-252021-04-2944,000— $044,000SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2020-10-112020-10-1320,000— $020,000SEC↗
Haasner DirkSVP, Global Regulatory Affai A Award deriv2020-10-112020-10-1320,000— $020,000SEC↗
Rona Jeffrey AChief Business Officer A Award deriv2020-10-112020-10-1320,000— $020,000SEC↗
Rona Jeffrey AChief Business Officer A Award deriv2020-09-302020-10-02325,000— $0325,000SEC↗
LEVIN JEREMY MCEO P Buy2020-08-282020-09-018,488$5.84 $49.6K5,792,530SEC↗
Tardio JasonChief Commercial Officer A Award deriv2020-06-192020-06-2350,000— $050,000SEC↗
Bernstein KarenDirector A Award deriv2020-06-052020-06-0813,250— $013,250SEC↗
Duncan Barbara GayleDirector A Award deriv2020-06-052020-06-0813,250— $013,250SEC↗
Friedman BartDirector A Award deriv2020-06-052020-06-0813,250— $013,250SEC↗
WILLIAMS DOUGLAS EDirector A Award deriv2020-06-052020-06-0813,250— $013,250SEC↗
Perone Thomas MichaelGeneral Counsel, Secretary A Award deriv2020-01-012020-01-0275,000— $075,000SEC↗
Perone Thomas MichaelSVP, General Counsel A Award deriv2019-12-182019-12-20100,000— $0100,000SEC↗
Daly TimothyEVP,Finance & Corp. Controll A Award deriv2019-12-182019-12-20125,000— $0125,000SEC↗
Haasner DirkSVP, Global Regulatory Affai A Award deriv2019-12-182019-12-20100,000— $0100,000SEC↗
LEVIN JEREMY MCEO A Award deriv2019-12-182019-12-20600,000— $0600,000SEC↗
Rakhit AmitPresident and CMO A Award deriv2019-12-182019-12-20200,000— $0200,000SEC↗
Tardio JasonChief Commercial Officer A Award deriv2019-11-182019-11-21125,000— $0125,000SEC↗
Bernstein KarenDirector A Award deriv2019-11-132019-11-157,437— $07,437SEC↗
Duncan Barbara GayleDirector A Award deriv2019-11-132019-11-157,437— $07,437SEC↗
Friedman BartDirector A Award deriv2019-11-132019-11-157,437— $07,437SEC↗
WILLIAMS DOUGLAS EDirector A Award deriv2019-11-132019-11-157,437— $07,437SEC↗
Daly TimothyEVP,Finance & Corp. Controll A Award deriv2019-11-012019-11-0425,000— $025,000SEC↗
Rakhit AmitPresident and CMO A Award deriv2019-11-012019-11-0475,000— $075,000SEC↗
LEVIN JEREMY MCEO P Buy2019-10-082019-10-1060,000$2.50 $150.0K4,736,529SEC↗
TAKEDA PHARMACEUTICAL CO LTD10% Owner P Buy2019-10-082019-11-222,000,000$2.50 $5.00M5,750,000SEC↗
LEVIN JEREMY MCEO G Gift2019-09-202024-02-14465,116— $00SEC↗
Bernstein KarenDirector A Award deriv2019-06-102019-08-015,813— $05,813SEC↗
Duncan Barbara GayleDirector A Award deriv2019-06-102019-08-015,813— $05,813SEC↗
WILLIAMS DOUGLAS EDirector A Award deriv2019-06-102019-08-015,813— $05,813SEC↗
Friedman BartDirector A Award deriv2019-06-102019-08-025,813— $05,813SEC↗
Bernstein KarenDirector A Award deriv2019-06-072019-06-105,813— $05,813SEC↗
Duncan Barbara GayleDirector A Award deriv2019-06-072019-06-105,813— $05,813SEC↗
WILLIAMS DOUGLAS EDirector A Award deriv2019-06-072019-06-105,813— $05,813SEC↗
Perone Thomas MichaelSVP, General Counsel A Award deriv2019-04-032019-04-08125,000— $0125,000SEC↗
During MatthewDirector, 10% Owner A Award deriv2019-04-012019-04-0375,000— $075,000SEC↗
Rakhit AmitCMO and PMO A Award deriv2019-04-012019-04-0350,000— $050,000SEC↗
Bernstein KarenDirector P Buy2019-02-262019-02-2810,000$2.02 $20.2K20,000SEC↗
During MatthewPresident and CSO A Award deriv2019-02-242019-02-2670,000— $070,000SEC↗
LEVIN JEREMY MCEO A Award deriv2019-02-242019-02-26250,000— $0250,000SEC↗
Haasner DirkSVP, Global Regulatory Affai A Award deriv2019-02-242019-02-2675,000— $075,000SEC↗
Ward AnaSVP and General Counsel A Award deriv2019-02-242019-02-2640,000— $040,000SEC↗
Daly TimothySVP,Finance & Corp. Controll A Award deriv2019-02-242019-02-2650,000— $050,000SEC↗
Rakhit AmitCMO and PMO A Award deriv2019-02-242019-02-26125,000— $0125,000SEC↗
LEVIN JEREMY MCEO P Buy2019-02-222019-02-2675,000$2.00 $150.0K4,676,529SEC↗
Haasner DirkSVP, Global Regulatory Affai A Award deriv2018-08-272018-08-2922,500— $022,500SEC↗
Rakhit AmitCMO and PMO A Award deriv2018-08-272018-08-2970,000— $070,000SEC↗
Daly TimothySVP,Finance & Corp. Controll A Award deriv2018-08-272018-08-2911,250— $011,250SEC↗
Ward AnaSVP and General Counsel A Award deriv2018-08-272018-08-2911,250— $011,250SEC↗
WILLIAMS DOUGLAS EDirector P Buy2018-08-142018-08-165,000$6.49 $32.5K5,000SEC↗
Bernstein KarenDirector P Buy2018-08-142018-08-1610,000$6.23 $62.3K10,000SEC↗
Bernstein KarenDirector A Award deriv2018-06-072018-06-085,813— $05,813SEC↗
Duncan Barbara GayleDirector A Award deriv2018-06-072018-06-085,813— $05,813SEC↗
Friedman BartDirector A Award deriv2018-06-072018-06-085,813— $05,813SEC↗
WILLIAMS DOUGLAS EDirector A Award deriv2018-06-072018-06-085,813— $05,813SEC↗
Daly TimothySVP,Finance & Corp. Controll A Award deriv2018-01-192018-01-2330,000— $030,000SEC↗
During MatthewPresident and CSO A Award deriv2018-01-192018-01-23110,000— $0110,000SEC↗
Haasner DirkSVP, Global Regulatory Affai A Award deriv2018-01-192018-01-2330,000— $030,000SEC↗
LEVIN JEREMY MCEO A Award deriv2018-01-192018-01-23290,000— $0290,000SEC↗
Rakhit AmitCMO and PMO A Award deriv2018-01-192018-01-2395,000— $095,000SEC↗
Ward AnaSVP and General Counsel A Award deriv2018-01-192018-01-2320,000— $020,000SEC↗
Werber YaronCBO, CFO, Sec. and Treas. A Award deriv2018-01-192018-01-23131,000— $0131,000SEC↗
Ward AnaSVP and General Counsel A Award deriv2017-09-052017-09-0695,000— $095,000SEC↗
LEVIN JEREMY MCEO P Buy2017-08-252017-08-2815,334$7.15 $109.6K4,601,529SEC↗
Duncan Barbara GayleDirector A Award deriv2017-06-142017-06-1511,627— $011,627SEC↗
Daly TimothyVP, Finance & Corp. Controll A Award deriv2017-05-102017-05-1046,510— $046,510SEC↗
During MatthewPresident and CSO C Conversion deriv2017-05-102017-05-1028,245— $00SEC↗
LEVIN JEREMY MCEO C Conversion deriv2017-05-102017-05-10400,150— $00SEC↗
LEVIN JEREMY MCEO C Conversion deriv2017-05-102017-05-1035,461— $00SEC↗
Werber YaronCBO, CFO, Sec. and Treas. A Award deriv2017-05-102017-05-1093,022— $093,022SEC↗
During MatthewPresident and CSO C Conversion2017-05-102017-05-1028,245— $04,307,314SEC↗
LEVIN JEREMY MCEO C Conversion2017-05-102017-05-1035,461— $035,461SEC↗
LEVIN JEREMY MCEO C Conversion2017-05-102017-05-10400,150— $04,586,195SEC↗